KR102411834B1 - 이식 결과 개선 및 췌장 세포 건강, 생존 향상을 위한 항-노화 글리코펩타이드들의 용도 - Google Patents

이식 결과 개선 및 췌장 세포 건강, 생존 향상을 위한 항-노화 글리코펩타이드들의 용도 Download PDF

Info

Publication number
KR102411834B1
KR102411834B1 KR1020167037011A KR20167037011A KR102411834B1 KR 102411834 B1 KR102411834 B1 KR 102411834B1 KR 1020167037011 A KR1020167037011 A KR 1020167037011A KR 20167037011 A KR20167037011 A KR 20167037011A KR 102411834 B1 KR102411834 B1 KR 102411834B1
Authority
KR
South Korea
Prior art keywords
group
isolated
cells
delete delete
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167037011A
Other languages
English (en)
Korean (ko)
Other versions
KR20170023029A (ko
Inventor
에이. 엠. 제임스 샤피로
래칠란 그랜트 영
Original Assignee
프로토키네틱스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프로토키네틱스 인코포레이티드 filed Critical 프로토키네틱스 인코포레이티드
Publication of KR20170023029A publication Critical patent/KR20170023029A/ko
Application granted granted Critical
Publication of KR102411834B1 publication Critical patent/KR102411834B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1020167037011A 2014-06-04 2015-06-02 이식 결과 개선 및 췌장 세포 건강, 생존 향상을 위한 항-노화 글리코펩타이드들의 용도 Active KR102411834B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462007626P 2014-06-04 2014-06-04
US62/007,626 2014-06-04
PCT/CA2015/050509 WO2015184544A1 (en) 2014-06-04 2015-06-02 Use of anti-aging glycopeptides to enhance pancreatic cell health, survival and improve transplant outcome

Publications (2)

Publication Number Publication Date
KR20170023029A KR20170023029A (ko) 2017-03-02
KR102411834B1 true KR102411834B1 (ko) 2022-06-21

Family

ID=54765902

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167037011A Active KR102411834B1 (ko) 2014-06-04 2015-06-02 이식 결과 개선 및 췌장 세포 건강, 생존 향상을 위한 항-노화 글리코펩타이드들의 용도

Country Status (8)

Country Link
US (5) US20150352155A1 (https=)
EP (1) EP3152297A4 (https=)
JP (1) JP6801934B2 (https=)
KR (1) KR102411834B1 (https=)
CN (1) CN106661549B (https=)
AU (1) AU2015271608B9 (https=)
NZ (1) NZ727749A (https=)
WO (1) WO2015184544A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3011449A1 (en) 2016-01-27 2017-08-03 Protokinetix Inc. Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
CA3012837A1 (en) 2016-02-04 2017-08-10 Czap Research And Development, Llc Controlled-release and stratified cyclodextrin inclusion complex vehicles
WO2021146812A1 (en) * 2020-01-24 2021-07-29 Protokinetix Inc. Use of anti-aging glycopeptides for inhibition of immune rejection of a graft
WO2021179081A1 (en) * 2020-03-10 2021-09-16 Protokinetix Inc. Use of anti-aging glycopeptides for treatment of dry eye disease, retinal degenerative diseases, or occular inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878851B1 (fr) * 2004-12-02 2007-02-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation en cryochirurgie et/ou cryopreservation
FR2900656A1 (fr) * 2006-05-03 2007-11-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation notamment pour la preservation de materiaux biologiques

Also Published As

Publication number Publication date
EP3152297A1 (en) 2017-04-12
US12521419B2 (en) 2026-01-13
US20210023142A1 (en) 2021-01-28
US20150352155A1 (en) 2015-12-10
US20230414675A1 (en) 2023-12-28
EP3152297A4 (en) 2018-01-31
AU2015271608A1 (en) 2017-01-12
CN106661549A (zh) 2017-05-10
US20260102436A1 (en) 2026-04-16
AU2015271608B2 (en) 2021-05-27
WO2015184544A1 (en) 2015-12-10
US20170360844A1 (en) 2017-12-21
AU2015271608B9 (en) 2021-06-17
CA2950963A1 (en) 2015-12-10
NZ727749A (en) 2023-04-28
CN106661549B (zh) 2022-02-11
JP6801934B2 (ja) 2020-12-16
JP2017520275A (ja) 2017-07-27
KR20170023029A (ko) 2017-03-02

Similar Documents

Publication Publication Date Title
US12521419B2 (en) Use of anti-aging glycopeptides to enhance pancreatic cell health, survival and improve transplant outcome
CN103917275B (zh) 用作免疫抑制剂的、分离自间充质干细胞的微囊泡
Lakey et al. Current status of clinical islet cell transplantation
KR101578591B1 (ko) 간엽줄기세포 및 면역조절 t 세포를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
CN105727250A (zh) 预防和治疗免疫病变和炎性疾病的包括用nod2激动剂处理的干细胞或其培养物的药物组合物
KR20150013154A (ko) 트레할로스 함유 폐색전 형성 예방용 포유동물 세포 현탁액
JP2023540885A (ja) 血小板由来ミトコンドリアを得るための方法及びその使用
JP2024081763A (ja) 膵臓移植のファシリテーターとして繊維芽細胞を用いる１型糖尿病の治療方法および組成物
Park et al. The effect of hydroxyethyl starch as a cryopreservation agent during freezing of mouse pancreatic islets
CA2950963C (en) Use of anti-aging glycopeptides to enhance pancreatic cell health, survival and improve transplant outcome
WO2017209270A1 (ja) ２５－ヒドロキシコレステロール又はその類縁体コレステロールを有効成分として含有してなる、活性化されたｔ細胞及び／又はｂ細胞に選択的な細胞死誘導剤又は細胞死促進剤
EP3407876A1 (en) Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
CN114762725B (zh) 一种治疗糖尿病的方法
US20230142705A1 (en) Use of anti-aging glycopeptides for inhibition of immune rejection of a graft
HK1237814B (zh) 抗衰老糖肽在增强胰腺细胞健康、存活以及改善移植效果的应用
HK1237814A1 (en) Use of anti-aging glycopeptides to enhance pancreatic cell health, survival and improve transplant outcome
KR20180080585A (ko) 현적 배양 기술을 이용한 인슐린 분비 능력 향상 세포 클러스터 제조방법
JP2016138087A (ja) 抗腫瘍剤
Briard The Rational Design and Use of Novel Small-Molecule Ice Recrystallization Inhibitors for the Cryopreservation of Hematopoietic Stem Cells and Red Blood Cells
KR20240061203A (ko) 자연살해세포 및 atra-나노겔을 유효성분으로 포함하는 섬유증 예방 및 치료용 약학 조성물
KR20130072387A (ko) 면역 억제용 약학적 조성물
Cheng Cellular Therapeutics-Based Strategies for Inducing Donor-Specific Tolerance to Vascularized Composite Allotransplants
WO2022143905A1 (zh) 一种治疗糖尿病的药物及其方法
Weiss et al. Wharton’s Jelly-Derived Mesenchymal Stromal Cells as Immunoregulatory Cells
CN103989701A (zh) 聚乙二醇4000或聚乙二醇6000在制备预防或治疗水母毒素心脏毒性药物中的应用

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20161229

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200602

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210728

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20220322

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220617

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220617

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20250331

Start annual number: 4

End annual number: 4